Passage of amyloid β protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease

Peptides

Volumn 23, Issue 12, 2002, Pages 2223-2226

  Banks, William A ^a   Terrell, Brie ^a   Farr, Susan A ^a   Robinson, Sandra M ^a   Nonaka, Naoko ^a,b,c   Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHOWA UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^c SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Amyloid precursor protein; Antibody; Blood brain barrier; Mice

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BLOOD BRAIN BARRIER; CLEARANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED ICR;

EID: 0036953160     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00261-9     Document Type: Article

References (30)

1. Advokat C., Gulati A. Spinal transection reduces both spinal antinociception and CNS concentration of systemically administered morphine in rats. Brain Res. 555:1991;251-258.
2. Bacskai B.J., Kajdasz S.T., Christie R.H., Carter C., Games D., Seubert P.et al. Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat. Med. 7:2001;369-372.
3. Balin B.J., Broadwell R.D., Salcman M., el Kalliny M. Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J. Comp. Neurol. 251:1986;260-280.
4. Banks W.A., Ortiz L., Plotkin S.R., Kastin A.J. Human interleukin (IL) 1α, murine IL-1α and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism. J. Pharmacol. Exp. Ther. 259:1991;988-996.
5. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H.et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer's disease. Nat. Med. 6:2000;916-919.
6. Blasberg R.G., Fenstermacher J.D., Patlak C.S. Transport of α-aminoisobutyric acid across brain capillary and cellular membranes. J. Cereb. Blood Flow Metab. 3:1983;8-32.
7. Broadwell RD, Bakder BJ, Banks WA, Friden PM, Moran M, Oliver C, et al. Ferrotransferrin and antibody against the transferrin receptor as potential vehicles for drug delivery across the mammalian blood-brain barrier into the central nervous system. In: Flanagan TR, Emerich DF, Winn SR, editors. Methods in neuroscience, vol. 21; 1994. p. 93-117. [Monograph].
8. Broadwell RD, Banks WA. Cell biological perspective for the transcytosis of peptides and proteins through the mammalian blood-brain fluid barriers. In: Pardridge WM, editor. The blood-brain barrier. New York: Raven; 1993. p. 165-99.
9. Broadwell R.D., Sofroniew M.V. Serum proteins bypass the blood-brain barrier for extracellular entry to the central nervous system. Exp. Neurol. 120:1993;245-263.
10. Chen G., Chen K.S., Knox J., Inglis J., Bernard A., Martin S.J.et al. A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease. Nature. 408:2000;975-979.
11. DeMattos R.B., Bales K.R., Cummins D.J., Paul S.M., Holtzman D.M. Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science. 295:2002;2264.
12. Flood J.F., Morley J.E. Age-related changes in footshock avoidance acquisition and retention in senescence accelerated mouse (SAM). Neurobiol. Aging. 14:1993;153-157.
13. Friden P.M., Walus L.R., Watson P., Doctrow S.R., Kozarich J.W., Backman C.et al. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science. 259:1993;373-377.
14. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
15. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S.et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
16. Kadota E., Muramatsu Y., Nonaka K., Karasuno M., Nishi K., Dote K.et al. Biological functions of extravasated serum IgG in rat brain. Acta Neurochir. Suppl. (Wien). 76:2000;69-72.
17. Kastin A.J., Akerstrom V., Pan W. Validity of multiple-time regression analysis in measurement of tritiated and iodinated leptin crossing the blood-brain barrier: meaningful controls. Peptides. 22:2001;2127-2136.
18. Kozlowski GP, Sterzl I, Nilaver G. Localization patterns for immunoglobulins and albumins in the brain suggest diverse mechanisms for their transport across the blood-brain barrier (BBB). In: Ermisch A, Landgraf R, Ruhle HJ, editors. Progress in brain research. Amsterdam: Elsevier; 1992. p. 149-54.
19. Kumar V.B., Farr S.A., Flood J.F., Kamlesh V., Franko M., Banks W.A.et al. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides. 21:2000;1769-1775.
20. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J.et al. Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408:2000;982-985.
21. Morley J.E., Kumar V.B., Bernardo A.F., Farr S.A., Uezu K., Tumosa N.et al. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides. 21:2000;1761-1767.
22. Patlak C.S., Blasberg R.G., Fenstermacher J.D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3:1983;1-7.
23. Peretz D., Williamson R.A., Kaneko K., Vergara J., Laclerc E., Schmitt-Ulms G.et al. Antibodies inhibit prion propagation and clear cell cultures of prion activity. Nature. 412:2001;739-743.
24. Preston E., Hynie I. Transfer constants for blood-brain barrier permeation of the neuroexcitatory shellfish toxin, domoic acid. Can. J. Neurol. Sci. 18:1991;39-44.
25. Ragusi C., Boschi G., Rips R., Scherrmann J.M. Facilitation of imipramine efflux from the brain by systemic specific antibodies. Br. J. Pharmacol. 118:1996;2152-2156.
26. Schabacker D.S., Kirschbaum K.S., Segre M. Exploring the feasability of an anti-idiotypic cocaine vaccine: analysis of the specificity of anticocaine antibodies (Ab1) capable of inducing Ab2beta anti-idiotypic antibodies. Immunology. 100:2000;48-56.
27. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T.et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
28. Schlachetzki F., Zhu C., Pardridge W.M. Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J. Neurochem. 81:2002;203-206.
29. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D.et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-327.
30. Zlokovic B.V., Yamada S., Holtzman D., Ghiso J., Frangione B. Clearance of amyloid β-peptide from brain: transport or metabolism? Nat. Med. 6:2000;718-719.